Findings from two studies, followed by a panel discussion featuring clinicians, researchers, and people with lived-living experience
Measuring meaningful outcomes in trials of medications for methamphetamine use disorder
Findings from a systematic review, and lived-living experience perspectives
Community-led approaches to drug monitoring and early warning: Lessons from the around the world
NCCRED and AIVL hosted a discussion on how lived-living experience perspectives can be meaningfully embedded in drug monitoring systems.
Next steps in prescription stimulants as a treatment for methamphetamine use disorder: Clinical implications of the LiMA trial
A discussion on the findings of the trial an expert panel discussion with clinicians, researchers and representatives with lived-living experience, and a live Q&A.
Digital interventions for methamphetamine use & First Nations people
A discussion on how digital health tools are being designed in partnership with First Nations communities to deliver culturally safe and accessible care.
Medication-assisted psychotherapy for methamphetamine use disorder
Examining emerging research into psilocybin- and ketamine-assisted psychotherapy as a treatment for methamphetamine use disorder.
